Fischer Medical Ventures Ltd — Board Meeting, 14-08-2025: Board Meeting

Fischer Medical Ventures' board has approved the financial results for the quarter and half-year. Consolidated revenue from operations stood at Rs 4.54 Cr, with a loss of Rs 0.61 Cr for the quarter. The 32nd Annual General Meeting will be held via video conferencing on September 29. The board also approved M/s Nuren Lodaya & Associates as Scrutinizer for e-voting and proposed their appointment as Secretarial Auditors for five years. Share transfer books will be closed from September 23 to September 29. An Independent Director, Dr. Jacob Thomas, resigned due to personal reasons.